Evaluation of dosing and clinical response to darbepoetin alfa (DA) and epoetin alfa (EPO) in patients treated for chemotherapy-induced anemia in hospital oncology outpatient clinics.

被引：0
作者：
Gupta, V
Rago, MA
Goetz, A
Fastenau, J
Watson, S
机构：
[1] Cardinal Hlth Clin Serv & Consulting, Pharmaceut & Clin Informat Serv, Houston, TX USA
[2] Ortho Biotech, Clin Affairs, Bridgewater, NJ USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5768
引用
收藏
页码：509B / 509B
页数：1
相关论文
共 50 条
[31]   ECONOMIC EVALUATION OF EPOETIN ALFA HEXAL (BINOCRIT) COMPARED TO DARBEPOETIN ALFA (ARANESP) IN THE TREATMENT OF CHEMOTHERAPY INDUCED ANEMIA (CIA) IN GERMANY [J].
Turner, M. ;
Walsh, K. ;
Whitehouse, J. .
VALUE IN HEALTH, 2013, 16 (07) :A399-A399
[32]   Phase II trial comparing darbepoetin alfa every 3-week versus weekly epoetin alfa for the treatment of chemotherapy-induced anemia [J].
Hassan, M. A. ;
Sleem, M. M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[33]   A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer [J].
Schwartzberg, LS ;
Yee, LK ;
Senecal, FM ;
Charu, V ;
Tomita, D ;
Wallace, J ;
Rossi, G .
ONCOLOGIST, 2004, 9 (06) :696-707
[34]   Effectiveness Of Biosimilar Epoetin Alfa For The Treatment Of Chemotherapy-Induced Anemia In Patients With Hematological Malignancies [J].
Agrawal, Samir G. ;
Guy, Andrea ;
O'Flaherty, Patricia ;
Turner, Matthew .
BLOOD, 2013, 122 (21)
[35]   A randomized, controlled trial comparing darbepoetin alfa correction/maintenance dosing with weekly dosing for treating chemotherapy-induced anemia [J].
Kotasek, Dusan ;
Canon, Jean-Luc ;
Mateos, Maria Victoria ;
Hedenus, Michael ;
Rossi, Greg ;
Taylor, Kerry .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (06) :1387-1401
[36]   Less frequently administered darbepoetin alfa is comparable to epoetin alfa for the treatment of chemotherapy-induced anemia: a pooled analysis of multicenter clinical trials conducted in the United States. [J].
Headlee, CS ;
Mirtsching, BC .
PHARMACOTHERAPY, 2003, 23 (10) :1353-1353
[37]   Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: The 20030125 study group trial [J].
Glaspy, John ;
Vadhan-Raj, Saroj ;
Patel, Ravi ;
Bosserman, Linda ;
Hu, Eddie ;
Lloyd, Richard E. ;
Boccia, Ralph V. ;
Tomita, Dianne ;
Rossi, Greg .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2290-2297
[38]   Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced AnaemiaEvidence from a 16-Week Randomised Trial [J].
Shelby D. Reed ;
Jasmina I. Radeva ;
Davey B. Daniel ;
Samir H. Mody ;
Jamie B. Forlenza ;
R. Scott McKenzie ;
Kevin A. Schulman .
PharmacoEconomics, 2006, 24 :479-494
[39]   Darbepoetin alfa dosed every 3 weeks in chemotherapy-induced anemia in patients with lung cancer [J].
Barata, F ;
Parente, B ;
Teixeira, E ;
Barroso, A ;
Figueiredo, A ;
Conde, S .
LUNG CANCER, 2005, 49 :S331-S331
[40]   Effectiveness of darbepoetin alfa administered every three weeks to elderly patients with chemotherapy-induced anemia [J].
Gasent, J. M. ;
Bermejo, J. C., II ;
Lopez, P. ;
Domenech, M. ;
Sanchez-Rovira, P. ;
Villadiego, K. ;
de Pedro, C. ;
Iturralde, P. ;
Gasquet, J. A. ;
Rodriguez, C. A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345